Need help locating data?
Data that informs the data visualisations can be found in the Data section of Cancer data in Australia (CdiA). The following table outlines the range of data provided within CdiA and can be used to assist in navigating through the various Excel workbooks of this report.
The table contains links to the various data and the respective visualisations the data informs. The Excel workbooks provide data for the many different cancers presented within each visualisation. Please note that estimates based on projections were made for the following: incidence data from 2020 to 2023, National Mortality Database mortality data from 2022 to 2023 and Australian Cancer Database mortality data from 2019 to 2023.
Book no. | Broad category (and period) | Contents | Relevant visualisations |
---|---|---|---|
1a | Cancer incidence 1982 to 2023 | Cancer incidence age-standardised rates (ASR) Crude cancer incidence rates Segi and WHO cancer incidence ASR Age specific cancer incidence rates by 5-year age groups Cases diagnosed by 5-year age groups | Summary Incidence by age |
1b | Cancer incidence 1982 to 2023 | Age-specific cancer incidence rates and counts of cancers diagnosed by 10-year age groups | Incidence by age |
1c | Cancer incidence 1982 to 2023 | Age-specific cancer incidence rates and counts of cancers diagnosed by 15-, 20-, 25- and 30-year age groups | Incidence by age |
1d | Cancer incidence 1982 to 2023 | Age-specific cancer incidence rates and counts of cancers diagnosed by 35-, 40-, 45- and 50-year age groups | Incidence by age |
2a | Cancer mortality 1971 to 2023 | Cancer mortality data based on the National Mortality Database: Cancer mortality ASRCrude cancer mortality rates Segi and WHO cancer mortality ASR Age-specific cancer mortality rates by 5-year age groups Deaths from cancer by 5-year age groups | Mortality by age |
2b | Cancer mortality 1971 to 2023 | Cancer mortality data based on the National Mortality Database: Age-specific cancer mortality rates and deaths from cancer (by 10-year age groups) | Mortality by age |
2c | Cancer mortality 1971 to 2023 | Cancer mortality data based on the National Mortality Database: Age-specific cancer mortality rates and deaths from cancer (by 15, 20, 25 and 30-year age groups) | Mortality by age |
2d | Cancer mortality 1971 to 2023 | Cancer mortality data based on the National Mortality Database: Age-specific cancer mortality rates and deaths from cancer by 35, 40, 45 and 50-year age groups | Mortality by age |
2e | Cancer mortality 2007 to 2023 | Cancer mortality data based on the Australian Cancer Database: Cancer mortality ASRCrude cancer mortality rates Age-specific cancer mortality rates and deaths by 5, 10, 15, 20, 25, 30, 35, 40, 45 and 50-year age groups. | Mortality by age |
3a | Cancer survival 1990–1994 to 2015–2019 periods | Cancer survival rates Cancer survival rates by 5-year age groups (2015–2019 only) Conditional cancer survival rates | Summary survival |
3b | Cancer survival 1990–1994 to 2015–2019 periods | Cancer survival rates Cancer survival rates by 20-year age groups Age-adjusted cancer survival rates | Survival by age |
4a | Cancer risk Incidence: 1982 to 2023 Mortality: 1971 for 2023 | Cancer risk adjusted for competing mortality, including: | Risk |
4b | Cancer risk Incidence: 1982 to 2023 Mortality: 1971 for 2023 | Cancer risk unadjusted for competing mortality, including: | Risk |
4c | Cancer risk Mortality: 2007 to 2023 | Cancer risk adjusted and unadjusted for competing mortality, including: Note: estimates for risk of death in this book are based on cancer deaths from the Australian Cancer Database. | Risk |
5 | Age at diagnosis/death Incidence: 1982 to 2019 Mortality: 1971 to 2021 | Median and mean age at cancer diagnosis | |
6 | Cancer prevalence as at 31 December 2018 | Number of people alive and diagnosed with cancer: within the last year within the last 5 years within the last 37 years | Summary |
7 | State and territory incidence data 1982 to 2019 | State and territory cancer incidence ASR State and territory number of cancer cases diagnosed | State and territory |
8 | Cancer incidence and survival by stage 2011 | Proportion of cases diagnosed by stage at diagnosis Cancer survival by stage at diagnosis Stage data is only available for melanoma of the skin, breast cancer in females, lung cancer, prostate cancer and colorectal cancer. | Stage |
9a | Cancer incidence by subsite 2000 to 2023 | Cancer incidence counts and rates by ICD-10 4-character subsite (crude and age-standardised rates and age-specific rates by 10-year age groups). Proportion of cancer by subsite (by 10-year age groups). | Cancer incidence by subsite |
9b | Cancer incidence by subsite 2000 to 2023 | Cancer incidence counts and rates by ICD-10 4-character subsite (crude and age-standardised rates and age-specific rates by 20-year age groups). Proportion of cancer by subsite (by 20-year age groups). | Cancer incidence by subsite |
9c | Cancer survival by subsite, 2000–2004 to 2015–2019 periods | Observed and relative survival rates by ICD-10 4-character (by 10-year age groups) 10-year age group proportions of cases diagnosed by ICD-10 4-character subsite | Cancer survival by subsite |
9d | Cancer survival by subsite, 2000–2004 to 2015–2019 periods | Observed and relative survival rates by ICD-10 4-character (by 20-year age groups) 20-year age group proportions of cases diagnosed by ICD-10 4-character subsite | Cancer survival by subsite |
10a to 10f | Incidence of selected cancers by histology 2001 to 2019 | Incidence counts and rates for selected cancers by histology (crude and age-standardised rates and age-specific rates by 10-year and 20-year age groups). Histology proportions for the selected cancers, by 10-year and 20-year age groups). Book 10a: Appendiceal cancer, breast cancer, brain cancer Book 10b: Colon cancer and colorectal cancer groups Book 10c: Cervical cancer, kidney cancer, liver cancer Book 10d: Lung cancer, melanoma of the skin, mesothelioma Book 10e: Pancreatic cancer, prostate cancer Book 10f: Rectosigmoid junction cancer and rectal cancer groups | Cancer incidence by histology |
10g to 10h | Survival for selected cancers by histology 2005–2009 to 2015–2019 | Observed and relative survival rates for selected cancers by histology Book 10g: by 10-year age groups Book 10h: by 20-year age groups | Cancer survival by histology |
10j | Histology frameworks for the selected cancers | Histology codes for the reported groups within each selected cancer | n.a. |
11a | Blood cancer incidence by histology (main reporting) | Finer level blood cancer incidence and rates for various blood cancers using the main blood cancer reporting framework (crude and age-standardised rates and age-specific rates by 10 and 20-year age groups) | Blood cancer incidence by histology (main reporting) |
11b | Blood cancer incidence by histology (main reporting) | Incidence proportions of blood cancers by type using the main blood cancer reporting framework (by 10 and 20-year age groups). | Blood cancer incidence by histology (main reporting) |
11c | Blood cancer incidence by histology (ICD-10 reporting) | Finer level blood cancer incidence and rates for various blood cancers using the ICD-10 blood cancer reporting framework (crude and age-standardised rates and age-specific rates by 10 and 20-year age groups) | Blood cancer incidence by histology (ICD-10) |
11d | Blood cancer incidence by histology (ICD-10 reporting) | Incidence proportions of blood cancers by type using the ICD-10 blood cancer reporting framework (by 10 and 20-year age groups). | Blood cancer incidence by histology (ICD-10) |
11e | Blood cancer survival by histology (main reporting) | Observed and relative survival rates for blood cancers using the main blood cancer reporting framework (by 10 and 20 year age groups) | Blood cancer survival by histology (main reporting) |
11f to 11g | Blood cancer survival by histology (ICD-10 by histology) | Observed and relative survival rates for blood cancers using the ICD-10 blood cancer reporting framework Book 10f: by 10-year age groups Book 10g: by 20-year age groups | Blood cancer survival by histology (ICD-10 reporting) |
11h | Main blood cancer reporting framework | Histology codes for the reported blood cancer groups | n.a. |
1e | Cancer incidence projections (2024 to 2033) | Cancer incidence projections (cases, age-standardised rates and crude rates) | n.a. |
Pivot | Cancer incidence by 3 character ICD-10 code (1982 to 2019) | Counts of cases diagnosed Age-specific and crude incidence rates | n.a. |